Experts discuss shifting CKD detection upstream, improving albuminuria screening, and enabling earlier, risk-based intervention.
Back
Connecting the Dots: Biomarkers Enabling Early CKD Identification in 2026
A series of clinical forums examining advances and best practices for the diagnosis of chronic kidney disease in a contemporary landscape.
Connecting the Dots: Biomarkers Enabling Early CKD Identification in 2026
Episodes
All
All
Experts discuss gaps in CKD detection, the role of albuminuria testing, and the need for earlier, risk-based care to improve outcomes.
New CKD therapies and a cardiometabolic care model are reshaping kidney disease management.
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Freenome Blood Test for Colorectal Cancer Screening
2
FDA Approves Centanafadine for ADHD in Adults, Children Aged ≥ 6 Years
3
Q&A: How to Optimize Pediatric Hypertension Diagnosis and Treatment
4
How FDA Approval of SimpleScreen CRC Could Expand Colorectal Cancer Screening With Mark Fendrick, MD
5